의료 진단용 인공지능 시장 : 컴포넌트, 테크놀러지, 애플리케이션, 최종사용자별 - 세계 예측(2025-2030년)

The Artificial Intelligence in Medical Diagnostics Market was valued at USD 1.00 billion in 2023, expected to reach USD 1.16 billion in 2024, and is projected to grow at a CAGR of 17.23%, to USD 3.04 billion by 2030.

The scope of Artificial Intelligence (AI) in Medical Diagnostics encompasses an array of applications, from image analysis and disease prediction to personalized medicine and workflow management. AI technologies like deep learning and natural language processing have become essential, offering enhanced accuracy and efficiency in diagnostic procedures. Their necessity stems from the growing demand for precision medicine, an increasing aging population, and a global surge in chronic diseases, pushing healthcare systems towards more reliable and quicker diagnostic solutions. Applications span across multiple domains such as radiology, pathology, and genomics, among others, with end-users being hospitals, diagnostic laboratories, and research centers.

Market insights reveal that the major growth drivers include advancements in machine learning algorithms, increasing healthcare expenditure, and the integration of AI with existing diagnostic equipment which improves operational efficiency. Furthermore, regulatory support and collaborations among tech firms and medical institutions are paving the way for innovative solutions. Opportunities abound in the form of emerging markets needing advanced healthcare solutions, as well as the development of AI tools that cater specifically to underserved pathologies like rare diseases. To capture these opportunities, companies should focus on strategic partnerships and investing in continuous algorithm training.

Conversely, limitations such as data privacy concerns, regulatory barriers, and the lack of standardized protocols challenge market growth. The high cost of AI solutions and the need for skilled personnel further inhibit widespread adoption. Addressing these challenges requires innovation particularly in data security, cost-effective AI tools, and training programs for healthcare professionals to foster user adoption. Research into hybrid AI models that can handle multimodal data more effectively could provide a competitive edge. The market is dynamic, characterized by rapid technological advancements and an increasing number of firms entering the space, necessitating agility and continuous innovation to maintain a competitive stance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Medical Diagnostics Market

The Artificial Intelligence in Medical Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic diseases and need for enhanced imaging analysis
  • Government initiatives to promote the integration of AI/ML technologies in healthcare
  • Adoption of AI technologies in precision medicine and wearable devices
• Market Restraints
  • Chances of failures and difficulty of integration with existing systems
• Market Opportunities
  • Introduction of diagnostic robotics and advanced AI technologies for medical diagnosis
  • Advancing start-up ecosystem and expansion of smart hospitals
• Market Challenges
  • Concerns regarding data privacy and security breaches

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Medical Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Medical Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Medical Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Medical Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Medical Diagnostics Market

A detailed market share analysis in the Artificial Intelligence in Medical Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Medical Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Medical Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Medical Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Persistent Systems Limited, Digital Diagnostics Inc., Enlitic, Inc., Stryker Corporation, 3M Company, Google LLC by Alphabet Inc., NEC Corporation, Microsoft Corporation, Nano-X Imaging Ltd., Johnson & Johnson Services, Inc., Edifecs, Inc., Corti - AI, Medtronic PLC, International Business Machines Corporation, Hewlett Packard Enterprise Development LP, Butterfly Network, Inc., Cera Care Limited, Epredia by PHC Holdings Corporation, Kantify, Cisco Systems, Inc., Aidoc Medical Ltd., GE HealthCare Technologies, Inc., Imagen Technologies, Inc., Qure.ai Technologies Private limited, Siemens Healthineers AG, Intel Corporation, Freenome Holdings, Inc., Koninklijke Philips N.V., VUNO Inc., NVIDIA Corporation, SigTuple Technologies Private Limited, Tempus Labs, Inc., AiCure, LLC, and General Vision, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Medical Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Hardware, Services, and Software. The Services is further studied across Tele Monitoring and Tele-Consultation.
• Based on Technology, market is studied across Computer Vision, Machine Learning Platforms, Natural Language Processing, and Robotic Processes Automation.
• Based on Application, market is studied across Cardiology, Neurology, Oncology, Ophthalmology, Pathology, and Pulmonology.
• Based on End-User, market is studied across Academic Institutions & Research Center, Diagnostic Center, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases and need for enhanced imaging analysis
    • 5.1.1.2. Government initiatives to promote the integration of AI/ML technologies in healthcare
    • 5.1.1.3. Adoption of AI technologies in precision medicine and wearable devices
  • 5.1.2. Restraints
    • 5.1.2.1. Chances of failures and difficulty of integration with existing systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of diagnostic robotics and advanced AI technologies for medical diagnosis
    • 5.1.3.2. Advancing start-up ecosystem and expansion of smart hospitals
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns regarding data privacy and security breaches
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Availability of a diverse range of software components to offer enhanced diagnostics decision
  • 5.2.2. Technology: Extensive advancements in computer vision technologies for improved image analysis
  • 5.2.3. Application: Adoption of AI in cardiology segment to enhance diagnostic accuracy
  • 5.2.4. End-User: Utilization of AI for large data set diagnosis in hospitals and clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Intelligence in Medical Diagnostics Market, by Component

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Services
  • 6.3.1. Tele Monitoring
  • 6.3.2. Tele-Consultation
• 6.4. Software

7. Artificial Intelligence in Medical Diagnostics Market, by Technology

• 7.1. Introduction
• 7.2. Computer Vision
• 7.3. Machine Learning Platforms
• 7.4. Natural Language Processing
• 7.5. Robotic Processes Automation

8. Artificial Intelligence in Medical Diagnostics Market, by Application

• 8.1. Introduction
• 8.2. Cardiology
• 8.3. Neurology
• 8.4. Oncology
• 8.5. Ophthalmology
• 8.6. Pathology
• 8.7. Pulmonology

9. Artificial Intelligence in Medical Diagnostics Market, by End-User

• 9.1. Introduction
• 9.2. Academic Institutions & Research Center
• 9.3. Diagnostic Center
• 9.4. Hospitals

10. Americas Artificial Intelligence in Medical Diagnostics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Artificial Intelligence in Medical Diagnostics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Medical Diagnostics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. XtalPi and CK Extend Partnership to Develop AI Cancer Diagnostic Models
  • 13.3.2. VUNO Secures FDA 510(k) Clearance for VUNO Med-DeepBrain
  • 13.3.3. Aidoc Expands its Partnership with GLEAMER to Enhance its Chest Imaging AI Suite
  • 13.3.4. Enlitic and Blackford Join Forces to Revolutionize Medical Imaging Data Standardization
  • 13.3.5. GE HealthCare Signs USD 44 Million Contract with BARDA to Develop Artificial Intelligence-Augmented Ultrasound Technology to Aid Clinicians in Diagnosing and Treating Traumatic Injury
  • 13.3.6. Nanox Announces Strategic Manufacturing Agreement with Varex Imaging Corporation to Advance the Nanox.ARC Medical Imaging System
  • 13.3.7. Corti's AI-Powered Healthcare Solution Attracts USD 60 Million Investment
  • 13.3.8. Aidoc Launches AI-based Full Brain Solution for Stroke Detection
  • 13.3.9. Butterfly Network Announces New FDA-Cleared AI-Enabled Lung Tool
  • 13.3.10. SigTuple Raises USD 4.3 Million in Series C Round
  • 13.3.11. GE HealthCare to Acquire Caption Health, Expanding Ultrasound to Support New Users Through FDA-Cleared, AI-Powered Image Guidance
  • 13.3.12. Microsoft Strikes Partnership with Paige to Advance Cancer Diagnostics and Treatment

Companies Mentioned

• 1. Persistent Systems Limited
• 2. Digital Diagnostics Inc.
• 3. Enlitic, Inc.
• 4. Stryker Corporation
• 5. 3M Company
• 6. Google LLC by Alphabet Inc.
• 7. NEC Corporation
• 8. Microsoft Corporation
• 9. Nano-X Imaging Ltd.
• 10. Johnson & Johnson Services, Inc.
• 11. Edifecs, Inc.
• 12. Corti - AI
• 13. Medtronic PLC
• 14. International Business Machines Corporation
• 15. Hewlett Packard Enterprise Development LP
• 16. Butterfly Network, Inc.
• 17. Cera Care Limited
• 18. Epredia by PHC Holdings Corporation
• 19. Kantify
• 20. Cisco Systems, Inc.
• 21. Aidoc Medical Ltd.
• 22. GE HealthCare Technologies, Inc.
• 23. Imagen Technologies, Inc.
• 24. Qure.ai Technologies Private limited
• 25. Siemens Healthineers AG
• 26. Intel Corporation
• 27. Freenome Holdings, Inc.
• 28. Koninklijke Philips N.V.
• 29. VUNO Inc.
• 30. NVIDIA Corporation
• 31. SigTuple Technologies Private Limited
• 32. Tempus Labs, Inc.
• 33. AiCure, LLC
• 34. General Vision, Inc.